Publication: Diagnostic applications of newborn screening for α-thalassaemias, haemoglobins E and H disorders using isoelectric focusing on dry blood spots
1
Issued Date
2014-01-01
Resource Type
ISSN
17581001
00045632
00045632
Other identifier(s)
2-s2.0-84898681794
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Annals of Clinical Biochemistry. Vol.51, No.2 (2014), 237-247
Suggested Citation
Punyanuch Jindatanmanusan, Suchada Riolueang, Waraporn Glomglao, Yaowapa Sukontharangsri, Sangkae Chamnanvanakij, Kitti Torcharus, Vip Viprakasit Diagnostic applications of newborn screening for α-thalassaemias, haemoglobins E and H disorders using isoelectric focusing on dry blood spots. Annals of Clinical Biochemistry. Vol.51, No.2 (2014), 237-247. doi:10.1177/0004563213491078 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/33404
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Diagnostic applications of newborn screening for α-thalassaemias, haemoglobins E and H disorders using isoelectric focusing on dry blood spots
Other Contributor(s)
Abstract
Background: Neonatal screening for haemoglobin (Hb) disorders is a standard of care in several developed countries with the main objective to detect Hb S. Such practice has not been established in Thailand where α-thalassaemia and haemoglobin E (Hb E) are highly prevalent. Early identification of thalassaemias could be helpful and strengthen the programme for prevention and control for severe thalassaemias. Methods: Data from isoelectric focusing (IEF) and Isoscan® for detecting types and amount (%) of each haemoglobin in 350 newborn's dried blood spots were analysed and compared with the comprehensive genotype analysis by DNA studies as a gold standard. Results: Based on genetic profiles, there were 10 different categories: (1) normal (n = 227), (2) α+-thalassaemia trait (n = 14), (3) α0-thalassaemia trait (n = 13), (4) β0-thalassaemia trait (n = 7), (5) Hb E trait (n = 72), (6) Hb E trait with α0-thalassaemia or homozygous α+-thalassaemia (n = 5), (7) Hb E trait with α+-thalassaemia trait (n = 5), (8) homozygous Hb E (n = 3), (9) homozygous Hb E with α+-thalassaemia trait (n = 1) and (10) Hb H disease (n = 3). The presence of Hb Bart's and Hb E were used to identify cases with a-thalassaemia and Hb E, respectively. We set 0.25% of Hb Bart's and 1.5% of Hb E as a cut-off level to detect α+-thalassaemia trait (sensitivity 92.86% and specificity 74.0%) and Hb E trait with 100% of both sensitivity and specificity for IEF diagnosis. Conclusion: Although molecular diagnosis seems to be better for definitive diagnosis of thalassaemia syndromes at birth, however, using our reference range described herein, IEF can be applied in a resource-limiting setting with acceptable reliability. © The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.